PASSAGE BIO INC (PASG) Stock News

USA - Nasdaq - NASDAQ:PASG - US7027122099 - Common Stock

8.83 USD

-0.16 (-1.78%)

Last: 11/28/2025, 7:54:08 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

PASG Latest News, Press Relases and Analysis

All

Press Releases

20 days ago - By: Passage Bio

Passage Bio Reports Third Quarter 2025 Financial Results and Provides Recent Business Highlights

20 days ago - By: Passage Bio

Passage Bio Reports Third Quarter 2025 Financial Results and Provides Recent Business Highlights

25 days ago - By: Passage Bio

Passage Bio to Present at Guggenheim Securities 2nd Annual Healthcare Innovation Conference

25 days ago - By: Passage Bio

Passage Bio to Present at Guggenheim Securities 2nd Annual Healthcare Innovation Conference

2 months ago - By: Passage Bio

Passage Bio to Participate in Chardan’s 9th Annual Genetic Medicines Conference

2 months ago - By: Passage Bio

Passage Bio to Participate in Chardan’s 9th Annual Genetic Medicines Conference

3 months ago - By: Zacks Investment Research

Wall Street Analysts Think Passage Bio (PASG) Could Surge 731%: Read This Before Placing a Bet

3 months ago - By: Passage Bio

Passage Bio to Participate in H.C. Wainwright 27th Annual Global Investment Conference

3 months ago - By: Passage Bio

Passage Bio to Participate in H.C. Wainwright 27th Annual Global Investment Conference

4 months ago - By: Zacks Investment Research

Wall Street Analysts Believe Passage Bio (PASG) Could Rally 1415.15%: Here's is How to Trade

4 months ago - By: Benzinga - Mentions: PRPH AZTR FGEN MYO ...

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

4 months ago - By: Passage Bio

Passage Bio Reports Second Quarter 2025 Financial Results and Provides Recent Business Highlights

4 months ago - By: Passage Bio

Passage Bio Reports Second Quarter 2025 Financial Results and Provides Recent Business Highlights

4 months ago - By: Benzinga - Mentions: IVA PIII TTNP HCTI ...

12 Health Care Stocks Moving In Friday's Intraday Session

5 months ago - By: Passage Bio

Passage Bio Announces 1-for-20 Reverse Stock Split

5 months ago - By: Passage Bio

Passage Bio Announces 1-for-20 Reverse Stock Split

5 months ago - By: Passage Bio

Passage Bio Reports Updated Interim Data from upliFT-D Study and Provides Program Update

5 months ago - By: Passage Bio

Passage Bio Reports Updated Interim Data from upliFT-D Study and Provides Program Update

7 months ago - By: Passage Bio

Passage Bio Reports First Quarter 2025 Financial Results and Provides Recent Business Highlights

7 months ago - By: Passage Bio

Passage Bio Reports First Quarter 2025 Financial Results and Provides Recent Business Highlights

9 months ago - By: Passage Bio

Passage Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Recent Business Highlights

9 months ago - By: Passage Bio

Passage Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Recent Business Highlights

9 months ago - By: Passage Bio

Passage Bio to Participate in Upcoming Investor Conferences

9 months ago - By: Passage Bio

Passage Bio to Participate in Upcoming Investor Conferences

a year ago - By: Passage Bio

Passage Bio Announces Interim Data from upliFT-D Study in FTD-GRN and Provides Business Updates

a year ago - By: Passage Bio

Passage Bio Reports Third Quarter 2024 Financial Results and Provides Recent Business Highlights

a year ago - By: Passage Bio

Passage Bio Reports Third Quarter 2024 Financial Results and Provides Recent Business Highlights